Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 10-2013 | 07-2013 | 04-2013 | 01-2013 | 10-2012 | |
| Sales | 241 | 251 | 253 | 351 | 469 |
| Cost of Goods | 232 | 175 | 165 | 223 | 266 |
| Gross Profit | 9 | 76 | 88 | 128 | 203 |
| Operating Expenses | 71 | 100 | 86 | 122 | 97 |
| Operating Income | -62 | -23 | 2 | 7 | 106 |
| Interest Expense | 59 | 42 | 50 | 116 | 75 |
| Other Income | -5 | 7 | 0 | -2 | -31 |
| Pre-tax Income | -126 | -58 | -48 | -112 | N/A |
| Net Income Continuous | -126 | -58 | -48 | -112 | 31 |
| Net Income | $-126 | $-58 | $-48 | $-112 | $31 |
| EPS Basic Total Ops | -0.27 | -0.10 | -0.08 | -0.27 | 0.00 |
| EPS Basic Continuous Ops | -0.27 | -0.10 | -0.08 | -0.27 | 0.00 |
| EPS Diluted Total Ops | -0.27 | -0.10 | -0.08 | -0.27 | 0.00 |
| EPS Diluted Continuous Ops | -0.27 | -0.10 | -0.08 | -0.27 | 0.00 |
| EBITDA(a) | $-7 | $67 | $85 | $122 | $286 |